Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2005
11/03/2005WO2005102313A1 Preventive and/or therapeutic agent for chronic sinusitis
11/03/2005WO2005102301A2 Hydroxymethylbutyrate compositions and uses thereof
11/03/2005US20050245750 Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
11/03/2005US20050245741 Novel tricyclic spiropiperidines or spiropyrrolidines
11/03/2005US20050245609 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
11/03/2005US20050245597 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
11/03/2005US20050245576 Substituted pyrazoles
11/03/2005US20050245575 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
11/03/2005US20050245567 Novel quinuclidine derivatives and their use
11/03/2005US20050245564 Methods and compositions related to IRM compounds and toll-like receptor pathways
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245545 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245513 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245493 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
11/03/2005US20050245467 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
11/03/2005US20050244960 Preparation of type II pneumocytes from stem cells
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244508 Anti-spasmodic comprising xenon
11/03/2005US20050244412 Method and composition for regulating activity of regulatory T cells
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244340 Dry powder compositions
11/03/2005CA2807787A1 Hmb compositions and uses thereof
11/03/2005CA2564161A1 Melatonin and its use in preventing postoperative complications
11/03/2005CA2564066A1 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
11/03/2005CA2563684A1 Preventive and/or therapeutic agent for chronic sinusitis
11/03/2005CA2563556A1 Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
11/03/2005CA2562417A1 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005CA2560042A1 Hmb compositions and uses thereof
11/03/2005CA2559700A1 Benzoxazine for treating respiratory tract diseases
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591437A2 Interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591123A1 Uses of naringenin, naringin and salts thereof as expectorants in the treatment of cough, and compositions thereof
11/02/2005EP1591120A1 Receptor agonists
11/02/2005EP1591118A1 Use of melatonin in preventing postoperative complications
11/02/2005EP1590345A1 Xanthine derivatives as muscarinic receptor antagonists
11/02/2005EP1590327A1 Ccr8 inhibitors
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1589980A2 Methods of diagnosis and treatment of interstitial lung disease
11/02/2005EP1589946A2 Solution for nostril wash
11/02/2005EP1589943A2 Methods of treating lung diseases
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1450859A4 Methods and compositions for the diagnosis of asthma
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1200320B1 Valve with a two-component seal
11/02/2005EP1169244B1 Metering valve
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005CN1692161A Treatment for asthma or allergies
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
11/02/2005CN1691946A Application of tacrolimus (FK056) derivant united with beta2-excitomotor for treating asthma
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1691942A Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid
11/02/2005CN1225473C Method of preparing cyclic vasoactive peptides
11/02/2005CN1225281C Medicine for treating nasosinusitis
11/02/2005CN1225261C Spray for treating snore
11/02/2005CN1225251C Compound buccal lozenge of lectuce tea and its preparing process
11/02/2005CN1225208C Pharynx-clearing and throat-moistening health food
11/01/2005US6960692 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/01/2005US6960683 Antiinflammatory agents; autoimmune diseases; cardiovascular disorders
11/01/2005US6960661 [7-(3-chloro-4-methoxybenzlamino)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-ylmethoxy]acetic acid, synthesis thereof and intermediates used therein
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960597 Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
11/01/2005US6960588 Tryptase inhibitors
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960585 For therapy of inflammatory and immune diseases
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960573 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
10/2005
10/29/2005CA2564988A1 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100562A1 OSTEOPONTIN siRNA
10/27/2005WO2005099765A1 Liquid composition and process for producing the same
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099736A1 Antitumor remedy
10/27/2005WO2005099685A1 Liquid external preparation containing sodium cromoglycate
10/27/2005WO2005007699A8 Human antibody molecules for il-13
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
1 ... 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 ... 878